부산대학교 도서관

In Urologic Oncology: Seminars and Original Investigations September 2017 35(9):576-577

Dyrskjøt, L. ; Birkenkamp-Demtröder, K. ; Nordentoft, I. ; Strandgaard, T. ; Lindskrog, S.V. ; Milling, R.V. ; Körner, S.K. ; Brandt, S.B. ; Knudsen, M. ; Andreasen, T.G. ; Hansen, C.F. ; Lamy, P. ; Lam, G. ; Dohn, L.H. ; Fabrin, K. ; Carus, A. ; Petersen, A.C. ; Joensen, U.N. ; Pappot, H. ; Holt, P.S. ; Jensen, N.V. ; Agerbæk, M. ; Jensen, J.B.

In Annals of Oncology

Bjerggaard Jensen, J.; Birkenkamp-Demtröder, K.; Nordentoft, I.; Milling, R.V.; Körner, S.K.; Brandt, S.B.; Knudsen, M.; Lam, G.W.; Dohn, L.H.; Fabrin, K.; Carus, A.; Petersen, A.; Joensen, U.N.; Pappot, H.; Holt, P.S.; Jensen, N.V.; Agerbæk, M.; Dyrskjot, L.

Bjerggaard Jensen, J, Birkenkamp-Demtröder, K, Nordentoft, I, Milling, R V, Körner, S K, Brandt, S B, Knudsen, M, Lam, G W, Dohn, L H, Fabrin, K, Carus, A, Petersen, A, Joensen, U N, Pappot, H, Holt, P S, Jensen, N V, Agerbæk, M & Dyrskjot, L 2024, 'Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial', Annals of Oncology, vol. 35, no. Suppl. 2, 1960O, pp. S1133. https://doi.org/10.1016/j.annonc.2024.08.2045
Bjerggaard Jensen, J, Birkenkamp-Demtröder, K, Nordentoft, I, Milling, R V, Körner, S K, Brandt, S B, Knudsen, M, Lam, G W, Dohn, L H, Fabrin, K, Carus, A, Petersen, A, Joensen, U N, Pappot, H, Holt, P S, Jensen, N V, Agerbæk, M & Dyrskjot, L 2024, ' Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial ', Annals of Oncology, vol. 35, no. Suppl. 2, 1960O, pp. S1133 . https://doi.org/10.1016/j.annonc.2024.08.2045

Nordentoft, I.; Birkenkamp-Demtröder, K.; Lindskrog, S.V.; Strandgaard, T.; Milling, R.V.L.; Körner, S.K.; Brandt, S.B.; Cohen, Y.; Lauterman, T.; Lam, G.; Dohn, L.H.; Fabrin, K.; Carus, A.; Petersen, A.; Joensen, U.N.; Pappot, H.; Holt, P.S.; Jensen, N.V.; Katz-Ezov, T.; Afterman, D.; Oklander, B.; Agerbaek, M.; Jensen, J.B.; Dyrskjøt, L.

European Urology. 87:S957-S957

Dyrskjøt, L.; Birkenkamp-Demtröder, K.; Nordentoft, I.; Lindskrog, S.V.; Strandgaard, T.; Milling, R.V.; Körner, S.K.; Brandt, S.B.; Knudsen, M.; Andreasen, T.; Lam, G.; Dohn, L.H.; Fabrin, K.; Carus, A.; Petersen, A.; Joensen, U.N.; Pappot, H.; Holt, P.S.; Jensen, N.V.; Agerbaek, M.; Jensen, J.B.

European Urology. 87:S956-S956

Emil Christensen; Iver Nordentoft; Karin Birkenkamp-Demtröder; Sara K. Elbæk; Sia V. Lindskrog; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy; Mads Agerbæk; Jørgen B. Jensen; Lars Dyrskjøt

Clin Cancer Res
Christensen, E, Nordentoft, I, Birkenkamp-Demtroder, K, Elbæk, S K, Lindskrog, S V, Taber, A, Andreasen, T G, Strandgaard, T, Knudsen, M, Lamy, P, Agerbæk, M, Jensen, J B & Dyrskjøt, L 2023, 'Cell-free urine-and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer', Clinical Cancer Research, vol. 29, no. 8, pp. 1582–1591. https://doi.org/10.1158/1078-0432.CCR-22-3250

Radif D; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.; Agerbæk M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: lars@clin.au.dk.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Lars Dyrskjøt; Jørgen B. Jensen; Mads Agerbæk; Philippe Lamy; Michael Knudsen; Trine Strandgaard; Tine G. Andreasen; Ann Taber; Sia V. Lindskrog; Sara K. Elbæk; Karin Birkenkamp-Demtröder; Iver Nordentoft; Emil Christensen

Lars Dyrskjøt; Jørgen B. Jensen; Mads Agerbæk; Philippe Lamy; Michael Knudsen; Trine Strandgaard; Tine G. Andreasen; Ann Taber; Sia V. Lindskrog; Sara K. Elbæk; Karin Birkenkamp-Demtröder; Iver Nordentoft; Emil Christensen

Emil Christensen; Iver Nordentoft; Sara K. Elbæk; Karin Birkenkamp-Demtröder; Ann Taber; Tine G. Andreasen; Trine Strandgaard; Michael Knudsen; Philippe Lamy; Mads Agerbæk; Jørgen B. Jensen; Lars Dyrskjøt

Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Strandgaard T; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Birkbak NJ; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Kristjánsdóttir N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Kjær A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Andreasen TG; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Ahrenfeldt J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Pedersen JS; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Rasmussen AM; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Hermann GG; Department of Urology, Herlev Hospital, Copenhagen University, Copenhagen, Denmark.; Mogensen K; Department of Urology, Herlev Hospital, Copenhagen University, Copenhagen, Denmark.; Petersen AC; Department of Pathology, Aalborg University Hospital, Aalborg, Denmark.; Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center EMN, Erlangen, Germany.; Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany.; Horstmann M; Department of Urology, University Hospital Essen, Essen, Germany.; Nawroth R; Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.; Segersten U; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Sikic D; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; van Kessel KEM; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Urology, Amphia Ziekenhuis, Breda, the Netherlands.; Zwarthoff EC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Maurer T; Department of Urology and Martini-Klinik, University of Hamburg-Eppendorf, Hamburg, Germany.; Simic T; Institute of Medical and Clinical Biochemistry, Center for Redox Medicine, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Malmström PU; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO) and CIBERONC, Madrid, Spain.; Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.; Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO) and CIBERONC, Madrid, Spain.; Medicine and Life Sciences Department, Universitat Pompeu Fabra, Barcelona, Spain.; Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. lars@clin.au.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. lars@clin.au.dk.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Kjær A; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.; Kristjánsdóttir N; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.; Juul RI; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.; Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark.; Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.; Ahrenfeldt J; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark.; Strandgaard T; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.; Radif D; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.; Hodgson D; Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK.; Abbosh C; Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK.; Aerts HJWL; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA 02114, USA; Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, 6200 MD Maastricht, the Netherlands.; Agerbæk M; Department of Oncology, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark.; Jensen JB; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark; Department of Urology, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark.; Birkbak NJ; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark. Electronic address: nbirkbak@clin.au.dk.; Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark. Electronic address: lars@clin.au.dk.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Emil Christensen; Iver Nordentoft; Sara K. Elbæk; Karin Birkenkamp-Demtröder; Ann Taber; Michael Knudsen; Philippe Lamy; Mads Agerbæk; Jørgen B. Jensen; Lars Dyrskjøt

Cancer Research. 82:1275-1275

Taber, A; Christensen, E; Lamy, P; Nordentoft, I; Prip, FF; Lindskrog, CV; Birkenkamp-Demtröder, K; Okholm, TLH; Knudsen, M; Pedersen, JS; Steiniche, T; Agerbæk, M; Jensen, JB; Dyrskjøt, L

Urologic Oncology: Seminars and Original Investigations. 38(12):899-899

Raitila, A; Georgitsi, M; Karhu, A; Tuppurainen, K; Mäkinen, M J; Birkenkamp-Demtröder, K; Salmenkivi, K; Orntoft, T F; Arola, J; Launonen, V; Vahteristo, P; Aaltonen, L A

A, R, Georgitsi, M, Karhu, A, Tuppurainen, K, Mäkinen, M, Birkenkamp-Demtröder, K, Salmenkivi, K, Ørntoft, T F, Arola, J, Launonen, V, Vahteristo, P & Aaltonen, L A 2007, 'No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia', Endocrine-Related Cancer, vol. 14, no. 3, pp. 901-906. https://doi.org/10.1677/ERC-07-0025
Raitila, A, Georgitsi, M, Karhu, A, Tuppurainen, K, Mäkinen, M J, Birkenkamp-Demtröder, K, Salmenkivi, K, Orntoft, T F, Arola, J, Launonen, V, Vahteristo, P & Aaltonen, L A 2007, 'No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia', Endocrine-Related Cancer, vol. 14, no. 3, pp. 901-6. https://doi.org/10.1677/ERC-07-0025

Nielsen, k; Heegaard, S.; Vorum, H.; Birkenkamp-Demtröder, K.; Ehlers, N.; Orntoft, T.F.

Nielsen, K, Heegaard, S, Vorum, H, Birkenkamp-Demtröder, K, Ehlers, N & Orntoft, T F 2005, 'Altered expression of CLC, DSG3, EMP3, S100A2, and SLPI in corneal epithelium from keratoconus patients', Cornea, vol. 24, no. 6, pp. 661-8.

Munksgaard, P P; Mansilla, F; Brems Eskildsen, A-S; Fristrup, N; Birkenkamp-Demtröder, K; Ulhøi, B P; Borre, M; Agerbæk, M; Hermann, G G; Orntoft, T F; Dyrskjøt, L

Br J Cancer
British Journal of Cancer; Vol 105
Munksgaard, P, Mansilla, F, Brems-Eskildsen, A S, Fristrup, N, Birkenkamp-Demtröder, K, Ulhøi, B P, Borre, M, Agerbæk, M, Hermann, GG, Ørntoft, T F & Andersen, L D 2011, 'Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.', B J C, vol. 105(9). https://doi.org/10.1038/bjc.2011.404
Munksgaard, P P, Mansilla, F, Brems Eskildsen, A-S, Fristrup, N, Birkenkamp-Demtröder, K, Ulhøi, B P, Borre, M, Agerbæk, M, Hermann, G G, Orntoft, T F & Dyrskjøt, L 2011, 'Low ANXA10 expression is associated with disease aggressiveness in bladder cancer', B J C, vol. 105, no. 9, pp. 1379-87. https://doi.org/10.1038/bjc.2011.404

Bodil, Oster; Kasper, Thorsen; Philippe, Lamy; Tomasz K, Wojdacz; Lise Lotte, Hansen; Karin, Birkenkamp-Demtröder; Karina D, Sørensen; Søren, Laurberg; Torben F, Orntoft; Claus L, Andersen

International Journal of Cancer. 129:2855-2866

Nielsen, Kim; Vorum, Henrik; Fagerholm, P.; Birkenkamp-Demtröder, K.; Honore, Bent; Ehlers, Niels; Ørntoft, Torben Falck

Nielsen, K, Vorum, H, Fagerholm, P, Birkenkamp-Demtröder, K, Honore, B, Ehlers, N & Ørntoft, T F 2006, 'Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study.', Experimental Eye Research, vol. 82, pp. 201-209.

Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. Electronic address: iver.nordentoft@clin.au.dk.; Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Gonzalez S; C2i Genomics, New York, NY, USA.; Kuzman M; C2i Genomics, New York, NY, USA.; Levatic J; C2i Genomics, New York, NY, USA.; Glavas D; C2i Genomics, New York, NY, USA.; Ptashkin R; C2i Genomics, New York, NY, USA.; Smadbeck J; C2i Genomics, New York, NY, USA.; Afterman D; C2i Genomics, Haifa, Israel.; Lauterman T; C2i Genomics, Haifa, Israel.; Cohen Y; C2i Genomics, Haifa, Israel.; Donenhirsh Z; C2i Genomics, Haifa, Israel.; Tavassoly I; C2i Genomics, New York, NY, USA.; Alon U; C2i Genomics, Haifa, Israel.; Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Knudsen M; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Polak P; C2i Genomics, New York, NY, USA.; Zviran A; C2i Genomics, New York, NY, USA.; Oklander B; C2i Genomics, Haifa, Israel.; Agerbæk M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.; Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: lars@clin.au.dk.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE